TrialJournal for immunotherapy of cancer2024

Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: the INCREASE study.

Idris Bahce et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.